CHM 6.25% 1.7¢ chimeric therapeutics limited

CHM's Future, page-6

  1. 128 Posts.
    lightbulb Created with Sketch. 23
    By doing a lazy Friday arvo chatgdp search current SoC for GBM after surgery is Temozolomide which is worth around $200m in sales. Patent expiry was in 2013 before which annual sales were approx $920 million. So one could take a 3-5x sales figure from that and discount what you think is appropriate for the trial stage. My hope and guess would be well north of $15m.
 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
1.7¢
Change
0.001(6.25%)
Mkt cap ! $15.07M
Open High Low Value Volume
1.7¢ 1.9¢ 1.7¢ $45.06K 2.512M

Buyers (Bids)

No. Vol. Price($)
1 62187 1.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.8¢ 200000 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.